Business Restructuring At Rhone-Poulenc
French chemical and pharmaceutical company Rhone-Poulenc is restructuring its business to "reflect the importance of its pharmaceutical and animal and plant health businesses."
The changes will result in the Rhone-Merieux veterinary pharmaceuticals business and the Rhone-Poulenc Animal Nutrition division being transferred out of the health care unit and into what was the company's agricultural division, which will be renamed animal and plant health. The former health care sector will be renamed the pharmaceuticals sector.
Alan Godard, currently president of the agricultural sector, will head up the new animal and plant health division. The changes will take effect from Jaunary 1, 1997. R-P made it clear that the reorganization is not a prelude to the pharmaceutical business being separated out from the rest of the group.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze